Adherence and Out-of-Pocket Cost Among Medicare Beneficiaries Prescribed Oral Targeted Therapies for Advanced Prostate Cancer

BACKGROUND: Abiraterone and enzalutamide are high-cost oral therapies increasingly used to treat patients with advanced prostate cancer, carrying the potential for significant financial consequences to patients. We investigated coping and material measures of financial hardship of these therapies am...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer
Hoofdauteurs: Caram, Megan E.V., Oerline, Mary K., Dusetzina, Stacie, Herrel, Lindsey A., Modi, Parth K., Kaufman, Samuel R., Skolarus, Ted A., Hollenbeck, Brent K., Shahinian, Vahakn
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959094/
https://ncbi.nlm.nih.gov/pubmed/32926427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33176
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items